Au th or ' s pe rs on al co py NPY signaling through Y 1 receptors modulates thalamic oscillations
Julia Brill,Gunnar F. Kwakye,J. Huguenard
Abstract:Neuropeptide Y is the ligand of a family of G-protein coupled receptors (Y1 to Y6). In the thalamus, exogenous and endogenously released NPY can shorten the duration of thalamic oscillations in brain slices from P13 to P15 rats, an in vitro model of absence seizures. Here, we examine which Y receptors are involved in this modulation. Application of the Y1 receptor agonist Leu31Pro34NPY caused a reversible reduction in the duration of thalamic oscillations ( 26.6 7.8%), while the Y2 receptor agonist peptideYY(3–36) and the Y5 receptor agonist BWX-46 did not exert a significant effect. No Y receptor agonist affected oscillation period. Application of antagonists of Y1, Y2 and Y5 receptors (BIBP3226, BIIE0246 and L152,806, respectively) produced results consistent with those obtained from agonists. BIBP3226 caused a reversible disinhibition, an effect that increases oscillation duration (18.2 9.7%) while BIIE0246 and L152,806 had no significant effect. Expression of NPY is limited to neurons in the reticular thalamic nucleus (nRt), but Y1 receptors are expressed in both nRt and adjacent thalamic relay nuclei. Thus, intra-nRt or nRt to relay nucleus NPY release could cause Y1 receptor mediated inhibition of thalamic oscillations. # 2006 Elsevier Inc. All rights reserved. * Corresponding author. Tel.: +1 650 723 5522; fax: +1 650 723 1080. E-mail address: john.huguenard@stanford.edu (J.R. Huguenard). avai lable at www.sc iencedi rec t .com journal homepage: www.e lsev ier .com/ locate /pept ides 0196-9781/$ – see front matter # 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.peptides.2006.08.043 Au th or 's pe rs on al co py spike-wave like oscillations can readily be evoked in thalamic slices from young rats (P13–P15) by delivering single extracellular stimuli to the internal cap ule, the main corticothalamic and thalamocortical fiber tract [14]. A 3 Hz thalamic oscillations are an in vitro model of absence (spikewave) seizures in rats as well as in primates [28,29]. Indispensable components for generation of these oscillations are GABAB and AMPA receptors as well as T-type calcium channels [4], however, many other factors modulate oscillatory activity, e.g. HCN channels, neuropeptides and electrical synapses [3,16,17,18,27,34]. Neuropeptide Y (NPY) is an inhibitor of absence seizures [23] and thalamic oscillations [25]. Subsets of NPY receptors (Y1, Y2 and Y5 receptors) are expressed in nRt as well as relay nuclei [20,33]. In this report we investigate the involvement of the three Y receptor subtypes expressed in thalamus in the modulation of thalamic oscillations. We have previously reported that Y1 receptor blockade disinhibits thalamic network oscillations [25]. Little is known about the effectors of Y5 receptor activation. The fact that they are expressed in thalamic nuclei makes them a potential modulator of thalamic network oscillations. 2. Materials and methods 2.1. Slice preparation Experiments were conducted according to protocols approved by the Stanford Institutional Animal Care and Use Committee. Rats (postnatal days 12–15) were deeply anesthetized with 50 mg/kg sodium pentobarbital and decapitated. Brains were transferred into ice cold sucrose solution containing, in mM: 234 sucrose, 11 glucose, 24NaHCO3, 2.5KCl, 1.25NaH2PO4, 2MgSO4, and 0.5CaCl2, equilibrated with 95% O2/5% CO2. 400 mm horizontal slices were cut on a VT 1000S vibratome (Leica) at 4 8C in sucrose solution and trimmed to exclude hippocampus and cortex. Slices were incubated in a holding chamber filled with artificial cerebrospinal fluid (ACSF) containing, in mM: 126NaCl, 26NaHCO3, 2.5KCl, 1.25NaH3PO4, 2CaCl2, 2MgCl2, and 10 glucose, equilibrated with 95% O2/5% CO2, pH 7.4 at 32 8C for 1 h and subsequently in the same solution at room temperature. 2.2. Extracellular recordings Extracellular recordings were performed as described previously [14,25]. Briefly, thalamic slices were transferred to an interface recording chamber and superfused with modified ACSF containing 1 mM MgCl2, 0.02 mM bicuculline methiodide and 0.5 mM L-glutamine (both Sigma). After waiting at least 5 min to allow slices to equilibrate, extracellular multiple-unit activities in nRt were recorded using a monopolar tungsten electrode (0.2–2 MV; Frederick Haer) and a Grass amplifier (bandwidth 0.03–3 kHz). Data were digitized at 10 kHz and stored using pClamp software (Axon Instruments). Single extracellular 40 ms stimuli were delivered to the internal capsule through a bipolar sharpened tungsten electrode at intervals between 30 and 60 s. Y receptor agonists and antagonists were bath applied at 600 nM (agonists) or 1 mM (antagonists) for 5–10 min followed by drug washout for at least the same amount of time. Agonists used were: Leu31Pro34NPY (Y1 receptor agonist, Tocris), Peptide YY3–36 (PYY3–36, Y2 receptor agonist, Tocris) and BWX-46 (Y5 receptor agonist, Tocris). Antagonists used were: BIBP3226 (Y1 receptor, Bachem), BIIE0246 (Y2 receptor, Tocris), L152,806 (Y5 receptor, Tocris).